Worried about your State Pension income? Here are 2 FTSE 100 dividend stocks I’d buy today

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver improving income returns in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the State Pension amounting to just £8,767 per year, many retirees are likely to need a second income in older age.

Since the FTSE 100 appears to offer good value for money at the present time, with it having a dividend yield of around 4.5%, there are a number of opportunities to generate a growing passive income across the large-cap share universe.

With that in mind, here are two FTSE 100 stocks that could offer an improving income outlook, as well as relatively stable financial performance over the long term.

AstraZeneca

It’s been a difficult journey for pharmaceutical company AstraZeneca (LSE: AZN) over the last decade. It has seen its profitability fall heavily due to the loss of patents on key drugs, with this leading to a lack of dividend growth in recent years.

Now though, the company appears to be in a relatively strong position. It has invested heavily in its pipeline under a strategy that has sought to focus on core growth areas. This strategy is now expected to bear fruit, with the business forecast to post a rise in net profit of around 12% in the current year.

This could stimulate AstraZeneca’s dividend growth prospects, and lead to an improving income outlook for its investors. It now has a dividend yield of just 3.4%, but its potential to increase dividends at a pace that exceeds inflation could lead to a robust outlook from an income perspective.

Alongside this, the company’s defensive appeal could help it to outperform the wider FTSE 100 at a time when the prospects for the global economy remain highly uncertain.

Unilever

Unilever’s (LSE: ULVR) recent updates have shown that its current growth strategy is paying off. It has focused investment on fast-growing markets across the emerging world, with them now making up the lion’s share of its revenue. They are also the main catalyst behind the company’s growth rate, and are likely to remain so over the medium term as wages in countries such as China move higher at a rapid rate.

Like AstraZeneca, Unilever’s dividend yield is below that of the wider FTSE 100 at the present time. The consumer goods company is set to record an income return of just 2.9% in the current year. However, with its bottom line forecast to produce a gain of 10% this year and its dividend payments being covered 1.6 times by profit, the scope for a rapidly-rising dividend seems to be high.

Although Unilever may lack the defensive appeal of some of its FTSE 100 peers, its potential to enjoy above-average growth over the long run seems to be high. It has a wide range of popular brands in a number of different markets. This provides it with a wide economic moat which, alongside its growth potential, makes it an enticing income opportunity for the long term.

Peter Stephens owns shares of AstraZeneca and Unilever. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Could this cheap FTSE 100 stock be the next Rolls-Royce?

Paul Summers casts his eye over a battered-but-high-quality FTSE 100 stock. Is this the next top-tier company to stage a…

Read more »

ISA Individual Savings Account
Investing Articles

Hesitant over a Stocks and Shares ISA? Here’s a way to deal with scary markets

Volatile stock markets are scaring potential investors away from getting started with their first Stocks and Shares ISA in 2026.

Read more »

This way, That way, The other way - pointing in different directions
Market Movers

Standard Life’s announced a £2bn deal but its share price is largely unchanged. Why?

James Beard considers why the Standard Life share price didn’t take off today (15 April) after the group announced it…

Read more »

Happy parents playing with little kids riding in box
Investing Articles

Up 12% in a month, Hollywood Bowl is a UK dividend stock on a roll

This 5%-yielding dividend stock was one of the top performers in the FTSE 250 index today. What sent it flying…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

Young investors are taking the stock market on a rollercoaster ride. Here’s how retirees can buckle up

Mark Hartley reveals the volatile impact that younger investors are having on the stock market and how UK retirees can…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

£7,500 invested in Aviva shares 5 years ago is now worth…

A lump sum pumped into Aviva shares half a decade ago has grown a lot. Andrew Mackie looks at the…

Read more »

Young female hand showing five fingers.
Investing Articles

Could £20,000 invested in these 5 dividend shares produce £14,760 of passive income over the next 10 years?

James Beard considers the potential of dividend shares to deliver amazing levels of passive income. Here are five that have…

Read more »

Workers at Whiting refinery, US
Investing Articles

At 570p, is it too late to consider buying BP shares?

Since the end of February, when the conflict in the Middle East started, BP shares have soared nearly 20%. But…

Read more »